Therapeutic Asset Ratings

8,400 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Irinotecan Thyroid Cancer	Institut de Recherches Internationales Servier	P1/2	CCC (53)
Itraconazole Ovarian Carcinoma	AbbVie	P1/2	CCC (53)
Mitoxantrone Cancer	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P1/2	CCC (53)
Nivolumab Peritoneal Carcinomatosis	Enlivex Therapeutics RDO Ltd.	P1/2	CCC (53)
Pembrolizumab Advanced/Metastatic Solid Tumors	Merck Sharp & Dohme LLC	P1/2	CCC (53)
Pembrolizumab Locally Advanced or Metastatic Solid Tumors	Biocity Biopharmaceutics Co., Ltd.	P1/2	CCC (53)
Pembrolizumab Locally Advanced Solid Tumor	Mohammed Milhem	P1/2	CCC (53)
Pembrolizumab Nasopharyngeal Carcinoma	Novartis Pharmaceuticals	P1/2	CCC (53)
Polyiclc Locally Advanced Unresectable Breast Carcinoma	University of Southern California	P1/2	CCC (53)
Polyiclc Locally Advanced Urothelial Carcinoma	Mayo Clinic	P1/2	CCC (53)
Pralatrexate Mycosis Fungoides	City of Hope Medical Center	P1/2	CCC (53)
Pyrotinib Advanced Pancreatic Ductal Adenocarcinoma	Daniel Breadner	P1/2	CCC (53)
rc48-adc Advanced Pancreatic Ductal Adenocarcinoma	Daniel Breadner	P1/2	CCC (53)
Recombinant Flt3 Ligand Breast Cancer	University of Southern California	P1/2	CCC (53)
Recombinant Interleukin-12 Malignant Pancreatic Neoplasm	Zhejiang University	P1/2	CCC (53)
Regorafenib IDH-Wildtype Glioblastoma	Neonc Technologies, Inc.	P1/2	CCC (53)
Retifanlimab Cancer	Incyte Corporation	P1/2	CCC (53)
SONALA-001 Progressive Glioblastoma	Mayo Clinic	P1/2	CCC (53)
Tak-228 Stage IV Lung Cancer AJCC v8	M.D. Anderson Cancer Center	P1/2	CCC (53)
TESTOSTERONE UNDECYLATE Solid Carcinoma	Aminex Therapeutics, Inc.	P1/2	CCC (53)
Tisagenlecleucel Chronic Lymphocytic Leukemia	Benjamin Tomlinson	P1/2	CCC (53)
Tocilizumab Hepatocellular Carcinoma	Takeda	P1/2	CCC (53)
VERAPAMIL SLOW RELEASE Ischemic Stroke	Justin Fraser	P1/2	CCC (53)
(+)-VINCRISTINE Prolymphocytic Leukemia	Acerta Pharma BV	P1/2	CCC (53)
Zilovertamab Vedotin Burkitt Lymphoma	Merck Sharp & Dohme LLC	P1/2	CCC (53)

Showing 451 to 475 of 8,400 assets

PreviousPage 19 of 336Next